MedStar Community Clinical Research Center (MCCRC) has been designated a MAGI Blue Ribbon Site for excellence as a clinical research site.
The main focus of MCCRC is on the conduct of diabetes-related clinical trials, including diabetes prevention, treatment, and management of diabetes-related complications. MCCRC employs a team approach to the conduct of federal grant, commercially-sponsored, and investigator-initiated clinical trials. MCCRC is well known for its proven ability to recruit and retain underrepresented research participants while strongly contributing to racial and ethnic diversity throughout our clinical research program.
Launched in 2017, MAGI’s Blue Ribbon Site program seeks to promote a culture of excellence in the clinical research site community. The program publishes a directory of sites that are considered excellent. It also seeks to facilitate collaboration and communication between these sites while encouraging other sites to meet the standards of excellence as set forth by the program.
“MCCRC takes pride in our track record of robust recruitment and retention, which is a core element of MAGI’s determination that we are a site of excellence,” said Becky Montalvo, Executive Director of the MedStar Community Clinical Research Center. “It is a privilege to offer clinical trial participation to as many patients as possible and continue advancing health through research.”
Model Agreements & Guidelines International (MAGI) is streamlining clinical research by standardizing best practices for clinical operations, business, and regulatory compliance. With more than 10,000 members, all sides of the clinical research industry are represented. Learn more about the Blue Ribbon program here.
